Lan L. Gellert

1.3k total citations
30 papers, 959 citations indexed

About

Lan L. Gellert is a scholar working on Surgery, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lan L. Gellert has authored 30 papers receiving a total of 959 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 13 papers in Molecular Biology and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lan L. Gellert's work include Prostate Cancer Treatment and Research (7 papers), Renal cell carcinoma treatment (5 papers) and Bladder and Urothelial Cancer Treatments (5 papers). Lan L. Gellert is often cited by papers focused on Prostate Cancer Treatment and Research (7 papers), Renal cell carcinoma treatment (5 papers) and Bladder and Urothelial Cancer Treatments (5 papers). Lan L. Gellert collaborates with scholars based in United States, Singapore and Japan. Lan L. Gellert's co-authors include Peng Lee, Hikmat Al‐Ahmadie, Richard F. Ambinder, M. Victor Lemas, Peter E. Clark, Giovanna A. Giannico, Omar Hameed, Xuanyi Zou, Jian-Jun Wei and Garrett Daniels and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Lan L. Gellert

30 papers receiving 951 citations

Peers

Lan L. Gellert
Marie Ludvíková Czechia
Sung‐Im Do South Korea
Sergio Rodrı́guez-Cuevas Mexico
T Brown United States
Soo Kee Min South Korea
George Zogopoulos Canada
L. Austin Doyle United States
Pierre Bohanes United States
S. Bretti Italy
Yuko Sasajima Japan
Marie Ludvíková Czechia
Lan L. Gellert
Citations per year, relative to Lan L. Gellert Lan L. Gellert (= 1×) peers Marie Ludvíková

Countries citing papers authored by Lan L. Gellert

Since Specialization
Citations

This map shows the geographic impact of Lan L. Gellert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lan L. Gellert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lan L. Gellert more than expected).

Fields of papers citing papers by Lan L. Gellert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lan L. Gellert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lan L. Gellert. The network helps show where Lan L. Gellert may publish in the future.

Co-authorship network of co-authors of Lan L. Gellert

This figure shows the co-authorship network connecting the top 25 collaborators of Lan L. Gellert. A scholar is included among the top collaborators of Lan L. Gellert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lan L. Gellert. Lan L. Gellert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Spieker, Andrew J., Tarik Gheit, Michaël Herfs, et al.. (2022). Pathological characterization and clinical outcome of penile intraepithelial neoplasia variants: a North American series. Modern Pathology. 35(8). 1101–1109. 7 indexed citations
2.
Cha, Jeeyeon, et al.. (2018). Case of reversible diabetes mellitus in the setting of benign pheochromocytoma. SHILAP Revista de lepidopterología. 10. 1–3. 5 indexed citations
3.
Clark, Peter E., et al.. (2018). MAGI2 is an independent predictor of biochemical recurrence in prostate cancer. The Prostate. 78(8). 616–622. 13 indexed citations
4.
Love, Harold D., Shunhua Guo, Lan L. Gellert, et al.. (2017). TPX2 as a prognostic indicator and potential therapeutic target in clear cell renal cell carcinoma. Urologic Oncology Seminars and Original Investigations. 35(5). 286–293. 20 indexed citations
5.
Kapp, Meghan, Shanna A. Arnold, Lan L. Gellert, et al.. (2017). Core Needle Biopsy and Fine Needle Aspiration Alone or in Combination: Diagnostic Accuracy and Impact on Management of Renal Masses. The Journal of Urology. 197(6). 1396–1402. 7 indexed citations
6.
Goldstein, Jeffrey A., Alexander D. Borowsky, Joseph T. Roland, et al.. (2016). MAGI-2 in prostate cancer: an immunohistochemical study. Human Pathology. 52. 83–91. 16 indexed citations
7.
Goldstein, Jeffrey A., Joseph T. Roland, Lan L. Gellert, et al.. (2016). MAGI-2 Is a Sensitive and Specific Marker of Prostatic Adenocarcinoma. American Journal of Clinical Pathology. 146(3). 294–302. 8 indexed citations
8.
Giannico, Giovanna A., Shanna A. Arnold, Lan L. Gellert, & Omar Hameed. (2016). New and Emerging Diagnostic and Prognostic Immunohistochemical Biomarkers in Prostate Pathology. Advances in Anatomic Pathology. 24(1). 35–44. 9 indexed citations
9.
Parwani, Anil V., et al.. (2015). A Collision Tumor of Papillary Renal Cell Carcinoma and Oncocytoma: Case Report and Literature Review. American Journal of Clinical Pathology. 144(5). 811–816. 11 indexed citations
10.
Cajaiba, Mariana M., Geetika Khanna, Ethan A. Smith, et al.. (2015). Pediatric cystic nephromas: distinctive features and frequent DICER1 mutations. Human Pathology. 48. 81–87. 27 indexed citations
11.
Gellert, Lan L., Joshua I. Warrick, & Hikmat Al‐Ahmadie. (2015). Urothelial carcinoma with squamous differentiation—The pathologists׳ perspective. Urologic Oncology Seminars and Original Investigations. 33(10). 437–443. 22 indexed citations
12.
Cates, Justin, Lan L. Gellert, Henry Crist, et al.. (2015). Loss of FOXA1 Drives Sexually Dimorphic Changes in Urothelial Differentiation and Is an Independent Predictor of Poor Prognosis in Bladder Cancer. American Journal Of Pathology. 185(5). 1385–1395. 52 indexed citations
13.
Sfakianos, John P., Lan L. Gellert, Alexandra C. Maschino, et al.. (2014). The role of PTEN tumor suppressor pathway staining in carcinoma in situ of the bladder. Urologic Oncology Seminars and Original Investigations. 32(5). 657–662. 15 indexed citations
14.
Gellert, Lan L., Rohit Mehra, Ying‐Bei Chen, et al.. (2014). The Diagnostic Accuracy of Percutaneous Renal Needle Core Biopsy and Its Potential Impact on the Clinical Management of Renal Cortical Neoplasms. Archives of Pathology & Laboratory Medicine. 138(12). 1673–1679. 15 indexed citations
15.
Ren, Qinghu, Jiaqian Liang, Jian‐Jun Wei, et al.. (2014). Epithelial and stromal expression of miRNAs during prostate cancer progression.. PubMed. 6(4). 329–39. 38 indexed citations
16.
Daniels, Garrett, Yi‐Rong Li, Lan L. Gellert, et al.. (2013). TBLR1 as an androgen receptor (AR) coactivator selectively activates AR target genes to inhibit prostate cancer growth. Endocrine Related Cancer. 21(1). 127–142. 33 indexed citations
17.
Mahajan, Abhishek, Zhaojian Liu, Lan L. Gellert, et al.. (2010). HMGA2: A biomarker significantly overexpressed in high-grade ovarian serous carcinoma. Modern Pathology. 23(5). 673–681. 80 indexed citations
18.
Peng, Yi, Yirong Li, Lan L. Gellert, et al.. (2009). Androgen receptor coactivator p44/Mep50 in breast cancer growth and invasion. Journal of Cellular and Molecular Medicine. 14(12). 2780–2789. 25 indexed citations
19.
Jones, Richard J., Christopher D. Gocke, Yvette L. Kasamon, et al.. (2009). Circulating clonotypic B cells in classic Hodgkin lymphoma. Blood. 113(23). 5920–5926. 121 indexed citations
20.
Gellert, Lan L., Bin Jalaludin, & Miriam Levy. (2007). Hepatocellular carcinoma in Sydney South West: late symptomatic presentation and poor outcome for most. Internal Medicine Journal. 37(8). 516–522. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marie Ludvíková Breakdown of academic impact, for papers by Sung‐Im Do Breakdown of academic impact, for papers by Sergio Rodrı́guez-Cuevas Breakdown of academic impact, for papers by T Brown Breakdown of academic impact, for papers by Soo Kee Min Breakdown of academic impact, for papers by George Zogopoulos Breakdown of academic impact, for papers by L. Austin Doyle Breakdown of academic impact, for papers by Pierre Bohanes Breakdown of academic impact, for papers by S. Bretti Breakdown of academic impact, for papers by Yuko Sasajima
Rankless by CCL
2026